Moreover, previously SARS-CoV-2 infected participants that did not require respiratory support and developed LC exhibited higher levels of IFN-α and IFN-β compared to NLC with the same clinical characteristics. The gene discussed is IFNA1; the disease is laryngotracheoesophageal cleft.